Patient Square Capital’s Scholar Rock SRRK Stock Holding History

Patient Square Capital’s Portfolio SRRK Stock Details SRRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-154,000	Closed	-$5.45M	–	26
2025 Q2	$5.45M	Hold	154,000	–	–	1.97%	10
2025 Q1	$4.95M	Buy	154,000 +122,000	+381%	+$4.69M	2.05%	10
2024 Q4	$1.38M	Buy	+32,000	New	+$1.04M	0.52%	19

Other funds holding SRRK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Patient Square Capital's SRRK Position: Q3 2025 in Review

Patient Square Capital sold out of Scholar Rock (SRRK) in Q3 2025, closing a stake of 154,000 shares — an estimated $5.45M sold.

Patient Square Capital first reported a position in SRRK in Q4 2024 and held it in 3 quarters. The position peaked at $5.45M in Q2 2025. 241 funds tracked by Wall St. Rank hold SRRK as of Q3 2025.

Patient Square Capital reported no remaining Scholar Rock position as of Q3 2025 after selling out during the quarter.
Patient Square Capital sold 154,000 Scholar Rock shares in Q3 2025, an estimated $5.45M.
Patient Square Capital first reported a position in Scholar Rock in Q4 2024 and held it in 3 quarters.
Patient Square Capital's Scholar Rock position peaked at $5.45M in Q2 2025.
241 funds tracked by Wall St. Rank held Scholar Rock as of Q3 2025.

Based on Patient Square Capital's 13F filing for Q3 2025, filed 10 Nov 2025.